| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/01/2004 | US20040002053 Plant nitrogen regulatory P-PII genes |
| 01/01/2004 | US20040001893 Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| 01/01/2004 | US20040001866 Genetic engineered polypeptides; bactericide |
| 01/01/2004 | US20040001864 Using antigens; genetic enginering; gene expression of capsid; heat resistance |
| 01/01/2004 | US20040001855 Monocyte locomotion inhibitory factor |
| 01/01/2004 | US20040001854 Isolated, genetic engineered polypeptide |
| 01/01/2004 | US20040001853 Genetic engineering; immunoglobulins; hepatitis virus ; induce immunology response |
| 01/01/2004 | US20040001852 Deactivation antigen protein; anticancer agents; Aids therapy |
| 01/01/2004 | US20040001851 Polyvalent immunogen |
| 01/01/2004 | US20040001850 Dna sequences; genetic engineering |
| 01/01/2004 | US20040001849 Antigen library immunization |
| 01/01/2004 | US20040001848 Alzheimer's disease; vaccines; induction immunology response |
| 01/01/2004 | US20040001846 Prostate-specific membrane antigen and uses thereof |
| 01/01/2004 | US20040001845 Polypeptide vaccine; Aids therapy; stimulant immunology response |
| 01/01/2004 | US20040001844 Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040001843 Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections |
| 01/01/2004 | US20040001842 Inducing antibodies in situ; binding; antitumor agents, anticancer agents |
| 01/01/2004 | US20040001840 Cancer-linked gene as target for chemotherapy |
| 01/01/2004 | US20040001839 Anticancer agents; antiinflammatory agents; autoimmune diseases |
| 01/01/2004 | US20040001836 Mixture of polypeptide with carrier |
| 01/01/2004 | US20040001832 Childhood obesity; antidiabetic agents; culture product; hybrid nucleic acid |
| 01/01/2004 | US20040001829 Methods for selectively stimulating proliferation of T cells |
| 01/01/2004 | US20040001826 Genetic engineering; binding collagen to glycoprotein; hemostatic response to injury |
| 01/01/2004 | US20040001822 Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 01/01/2004 | US20040001810 Administering dosage of nucleic acids; cardiovascular disorders |
| 01/01/2004 | US20040001808 Compositions and methods for the use of Bcl-2 transfected neurons |
| 01/01/2004 | US20040001807 Genetic engineering bone marrow cells; therapy for cardiovascular disorders |
| 01/01/2004 | US20040001803 Effectors of innate immunity determination |
| 01/01/2004 | US20040001802 Immobilized tumor necrosis factor |
| 01/01/2004 | US20040001790 Methods for diagnosis and treatment of tumours |
| 12/31/2003 | WO2004001425A2 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins |
| 12/31/2003 | WO2004001424A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | WO2004001422A2 Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases |
| 12/31/2003 | WO2004001418A2 Method for identifying and extracting endotoxin |
| 12/31/2003 | WO2004001381A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 12/31/2003 | WO2004001103A2 Silk biomaterials and methods of use thereof |
| 12/31/2003 | WO2004001068A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/31/2003 | WO2004001060A2 Identification and regulation of a g-protein coupled receptor, rai-3 |
| 12/31/2003 | WO2004001056A1 Process for preparing g-csf |
| 12/31/2003 | WO2004001052A1 ISOLATION OF THE PEROXISOME PROLIFERATION-ACTIVATED RECEPTOR-GAMMA (PPARη) LIGAND AND METHODS OF USE THEREOF |
| 12/31/2003 | WO2004001051A2 Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 12/31/2003 | WO2004001046A1 Method of generating resistance against cucurbit yellow stunting disorder virus (cysdv) in plants, genetic constructions used and cysdv-resistant plants thus produced |
| 12/31/2003 | WO2004001039A1 Actinomyces-origin plasmid and process for producing secondary metabolite using the same |
| 12/31/2003 | WO2004001038A1 Novel gene and protein participating in neuralization of cells or tissues and utilization thereof |
| 12/31/2003 | WO2004001026A1 Method of preparing recombinant mononegaviruses and the applications thereof |
| 12/31/2003 | WO2004001022A1 Probiotic propionibacterium jensenii 702 |
| 12/31/2003 | WO2004001020A2 Methods and means to promote gut absorption |
| 12/31/2003 | WO2004001019A2 Novel nanoparticles and use thereof |
| 12/31/2003 | WO2004001012A2 Plant defensins |
| 12/31/2003 | WO2004001009A2 Apo-2 ligand/trail variants and uses thereof |
| 12/31/2003 | WO2004001005A2 Intracellular signaling proteins |
| 12/31/2003 | WO2004001004A2 Membrane associated tumor endothelium markers |
| 12/31/2003 | WO2004001003A2 Plastid division and related genes and proteins, and methods of use |
| 12/31/2003 | WO2004001001A2 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 12/31/2003 | WO2004000999A2 Identification of a receptor controlling migration and metastasis of skin cancer cells |
| 12/31/2003 | WO2004000997A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/31/2003 | WO2004000996A2 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation |
| 12/31/2003 | WO2004000915A2 Silk biomaterials and methods of use thereof |
| 12/31/2003 | WO2004000884A2 Compositions and methods for apo-b48 and apo-b100 assay |
| 12/31/2003 | WO2004000883A1 Regulation of human growth hormone-releasing hormone receptor |
| 12/31/2003 | WO2004000882A2 Proteins |
| 12/31/2003 | WO2004000881A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 12/31/2003 | WO2004000880A1 Method of binding a compound to a surface |
| 12/31/2003 | WO2004000879A1 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 12/31/2003 | WO2004000878A1 Immunogenic polypeptide isolated from Mycobacterium avium subspecies paratuberculosis and uses thereof |
| 12/31/2003 | WO2004000877A2 Peptides derived from the rabies virus glycoprotein g, ligands of the low-affinity receptor of neurotrophins (p75ntr) and applications thereof |
| 12/31/2003 | WO2004000876A1 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS |
| 12/31/2003 | WO2004000875A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 12/31/2003 | WO2004000873A2 Adjuvant-free peptide vaccine |
| 12/31/2003 | WO2004000870A2 Two synthetic peptides for treatment and prevention of cancers |
| 12/31/2003 | WO2004000415A2 Tissue reconstruction and regeneration |
| 12/31/2003 | WO2004000366A1 Pegylated factor vii glycoforms |
| 12/31/2003 | WO2004000346A1 Preventives/remedies for cancer |
| 12/31/2003 | WO2004000345A1 Preventives/remedies for bone and joint diseases |
| 12/31/2003 | WO2004000343A1 Recombinant polypeptide for immunocastration and vaccine comprising the same |
| 12/31/2003 | WO2004000236A2 Modified sodium iodide symporter proteins and genes for imaging and cancer therapy |
| 12/31/2003 | WO2004000233A2 Algal gdp-mannose-3',5'-epimerases and methods of use thereof |
| 12/31/2003 | WO2004000231A2 Methods and compositions for the treament of cancer |
| 12/31/2003 | WO2004000221A2 Compositions and methods for modulating lymphocyte activity |
| 12/31/2003 | WO2004000220A2 Methods for purifying viral particles for gene therapy |
| 12/31/2003 | WO2004000207A2 Toxin-phage bacteriocide antibiotic and uses thereof |
| 12/31/2003 | WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 12/31/2003 | WO2004000096A2 Novel bartonella antigen lysate extracts for use in elisa diagnostic |
| 12/31/2003 | WO2004000032A2 Colour reduction in canola protein isolate |
| 12/31/2003 | WO2004000031A1 Protein extraction from canola oil seed meal |
| 12/31/2003 | WO2004000007A2 Methods of modulating cytokinin related processes in a plant using b3 domain proteins |
| 12/31/2003 | WO2003089623A3 Genetic marker for endocrine disorders |
| 12/31/2003 | WO2003087308A3 Use of interleukin-24 to treat ovarian cancer |
| 12/31/2003 | WO2003087137A3 New therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 12/31/2003 | WO2003076658A3 A susceptibility gene for late-onset idiopathic parkinson's disease |
| 12/31/2003 | WO2003074675A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003067965A3 Identification and characterization of an glutamine dumper 1 phenotype (gdui1) in arabidopsis |
| 12/31/2003 | WO2003065795A3 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 12/31/2003 | WO2003064471A3 Gene for peripheral arterial occlusive disease |
| 12/31/2003 | WO2003062398A3 NEW TUMOR SUPPRESSOR GENE, p28ING5 |
| 12/31/2003 | WO2003057834A3 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 12/31/2003 | WO2003057719A3 Methods of modulating localization and physiological function of ip3 receptors |
| 12/31/2003 | WO2003057708A3 Fusion proteins |
| 12/31/2003 | WO2003056021A3 Modified tetracycline repressor protein compositions and methods of use |